Consider and approve the unaudited financial result for the quarter and half year ended September 30, 2025 and declaration of interim dividend
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Panchsheel Organics announced its unaudited results for Q2 and H1 FY26 (ended September 30, 2025). Revenue from Operations stood at Rs. 25.32 crore in Q2, down from Rs. 27.18 crore in Q2 FY25. Net Profit fell to Rs. 2.61 crore from Rs. 3.79 crore (a decline of ~31%). For H1 FY26, total income came in at Rs. 50.19 crore (vs Rs. 54.68 crore last year) and net profit at Rs. 5.45 crore (vs Rs. 7.21 crore). The board declared an interim dividend of Rs. 0.80 per share (8% on face value of Rs. 10), amounting to Rs. 105.37 lakhs in total payout. Record date is November 21, 2025, and payment will be made on or before December 13, 2025. Auditor Jayesh R Shah & Co. issued a clean (unmodified) limited review report.
Both revenue and profits declined year-on-year, which could weigh on near-term sentiment, but the board's decision to maintain an interim dividend signals continued confidence in cash generation. Shareholders on record by November 21, 2025 will receive the Rs. 0.80 per share dividend.